Maple Leaf Partners

Maple Leaf Partners is a private investment firm and hedge fund manager rather than a biotechnology, pharmaceutical, or healthcare operating company. Public business-directory, SEC-related, and financial-profile sources describe it as an investment manager/sponsor of pooled investment vehicles focused on public equity and related investment activities. The firm appears to operate under entities including Maple Leaf Partners LP and Maple Leaf Partners I LP, and it has been associated with Dane Andreeff. While it may invest in healthcare or biotech companies as part of its portfolio, there is no evidence that Maple Leaf Partners itself develops therapeutics, diagnostics, medical devices, or healthcare services.